Testing effectiveness (Phase 2)UnknownNCT02422719What this trial is testingRadotinib as 3rd or Later Line Therapy in CP-CMLWho this might be right forChronic Myeloid Leukemia Ulsan University Hospital 73
Testing effectiveness (Phase 2)Study completedNCT00064311What this trial is testingRavuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT00410657What this trial is testingAlemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT01279473What this trial is testingStudy to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)Who this might be right forChronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT01698905What this trial is testingTreatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)Who this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 163
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04060277What this trial is testingTriplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantationWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more City of Hope Medical Center 7
Testing effectiveness (Phase 2)Ended earlyNCT00392782What this trial is testingDonor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other DiseaseWho this might be right forLeukemiaMyelodysplastic Syndromes Masonic Cancer Center, University of Minnesota 24
Early research (Phase 1)Study completedNCT04609826What this trial is testingJNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)Who this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia Janssen Research & Development, LLC 153
Testing effectiveness (Phase 2)Study completedNCT00381550What this trial is testing3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeBlastic Phase Chronic Myelogenous Leukemia+7 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Ended earlyNCT00276159What this trial is testingStudy of Immune Response Modifier in the Treatment of Hematologic MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma+3 more Masonic Cancer Center, University of Minnesota 6
Not applicableStudy completedNCT00988013What this trial is testingIntensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaLymphoblastic LeukemiaAcute Leukemia+2 more University of Illinois at Chicago 14
Large-scale testing (Phase 3)Study completedNCT04948333What this trial is testingAsciminib Treatment Optimization in ≥ 3rd Line CML-CPWho this might be right forChronic Myelogenous Leukemia Novartis Pharmaceuticals 199
Not applicableStudy completedNCT00919425What this trial is testingS9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic CancerWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 1,294
Testing effectiveness (Phase 2)Study completedNCT00053001What this trial is testingThalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic SyndromeWho this might be right forAnemiaLeukemiaMyelodysplastic Syndromes+1 more Fallon Clinic
Early research (Phase 1)Study completedNCT00077467What this trial is testingBortezomib in Treating Young Patients With Refractory or Recurrent LeukemiaWho this might be right forBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Promyelocytic Leukemia (M3)Recurrent Childhood Acute Lymphoblastic Leukemia+1 more National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00004009What this trial is testingR115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous LeukemiaWho this might be right forLeukemia University of Maryland, Baltimore
Early research (Phase 1)Looking for participantsNCT05636514What this trial is testingCombined Evaluation of Epigenetic and Sensitising Therapy in AML and MDSWho this might be right forMyelodysplastic SyndromesChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia Clinical Hub for Interventional Research (CHOIR) 12
Early research (Phase 1)Study completedNCT01751919What this trial is testingA Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)Who this might be right forChronic Myeloid LeukemiaGastrointestinal Stromal Tumor Dong-A ST Co., Ltd. 37
Testing effectiveness (Phase 2)Study completedNCT00038597What this trial is testingPhase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)Who this might be right forMyelogenous Leukemia, Chronic M.D. Anderson Cancer Center 13